Testosterone
is the main male hormone that maintains muscle mass and strength, fat
distribution, bone mass, sperm production, sex drive, and potency. Testosterone
is considered to be the "Male Hormone".
Testosterone: A "male hormone" -- a sex hormone produced by the testes
that encourages the development of male sexual characteristics, stimulates
the activity of the male secondary sex characteristics, penis growth,
muscle development and Masculine features. Chemically, testosterone
is 17-beta-hydroxy-4-androstene-3-one. Testosterone is the most potent
of the naturally occurring androgens. The androgens in general also
cause the development of male sex characteristics, such as a deep voice
and a beard; they also strengthen muscle tone and bone mass.
High
levels of testosterone appear to promote good health in men, for example,
lowering the risks of high blood pressure and heart attack. High testosterone
levels also correlate with risky behavior, however, including increased
aggressiveness and smoking , which may cancel out these health benefits.
Testosterone therapy may be
given to treat medical conditions, including female (but not male)
breast cancer hypogonadism (low gonadal function) in the male,
cryptorchism (nondescent of the testis into the scrotum), and
menorrhagia (irregular periods).
Testosterone
is the primary androgenic hormone and is responsible for normal growth
and development of male sex organs and maintenance of secondary sex
characteristics. Pre-pubertal hypogonadism is generally characterized
by infantile genitalia and lack of virilization, while the development
of hypogonadism after puberty frequently results in complaints such
as diminished libido, erectile dysfunction, infertility, gynecomastia,
impaired masculinization, changes in body composition, reductions in
body and facial hair, and osteoporosis. Hypogonadal men also report
levels of anger, confusion, depression, and fatigue that are significantly
higher than those reported in eugonadal men (high testosterone men).
Evaluation
of potential candidates for testosterone replacement therapy should
include a complete medical history and hormonal screening. Total serum
testosterone should be measured in the morning. When the serum testosterone
level is low and LH is elevated, testosterone replacement therapy is
warranted. Patients with low serum LH and testosterone levels need an
imaging study of their pituitary and may need endocrinologic consultation.
Testosterone
is a male hormone produced by the testes and responsible for producing
and maintaining male sex characteristics. The testes is the male reproductive
gland. Testosterone is the major androgenic hormone made by the testes
in response to luteinizing hormones from the pituitary gland. Testosterone
hormones promote the development of adult male characteristics including
deep voice, strong muscle and bone mass, and sperm. High levels of testosterone
promote good health in men and lower the risk of high blood pressure
and heart attack. Testosterone also stimulates metabolism and the burning
of body fat. During puberty, testosterone levels are at a lifetime peak.
These levels begin to decline about the age of 23.
- Increased muscle strength and mass.
- Increased sexual potency and frequency.
- Lowers cholesterol levels.
- Increased energy, stamina and endurance.
- Improved mental function
- Improves mood and feeling of well-being.
- Protects against heart disease
- Improved concentration and focus
- Reduced libido
- Fatigue or a decrease in physical stamina
- Difficulty in maintaining erections
- Memory impairment,
- Depression and anxiety
- Increased risk of heart disease,
- Decreased muscle mass
- Weight Gain

PHARMACOLOGICAL CLASSIFICATIONS
Category A 21.7 (Male sex hormones)
PHARMACOLOGICAL ACTION
In the eunuch and eunuchoid male, androgens act to stimulate and maintain
the secondary sexual characteristics associated with the adult male.
Androgens influence closure of the epiphyseal lines in males and some
females, administration of androgens reduces urinary excretion of nitrogen,
sodium, potassium, chloride, phosphorus and water.
INDICATIONS
Based on a review by the National Academy of Sciences - National Research
Council and/or other information, FDA has classified the indications
for certain androgens as follows:
Effective - In the male:
* Eunuchism, eunuchoidism, deficiency after castration.
* Male climacteric symptoms when these are secondary to androgen deficiency.
* Oligospermia.
Probably Effective - In the female or male:
* Postmenopausal or senile osteoporosis. Androgens are without value
as a primary therapy, but may be of value as adjunctive therapy. Equal
or greater consideration should be given to diet, calcium balance, physiotherapy,
and good general health-promoting measures. Final classification of
the less-than-effective indications requires further investigation.
CONTRA-INDICATIONS
* Carcinoma of the male breast.
* Carcinoma known or suspected of the prostate.
* Cardiac, hepatic or renal decompensation.
* Hypercalcaemia.
* Liver function impairment.
* Prepubertal males.
* Pregnancy.
DOSAGE AND DIRECTIONS FOR USE
TESTOSTERONE is for intramuscular use only. Dosage will vary depending
upon the individual, the condition being treated, its severity, and
prior androgen therapy. Because of the protracted action of TESTOSTERONE
injections more frequently than every two weeks are seldom required.
Eunuchism; Eunuchoidism - For complete replacement in eunuchs and eunuchoid
patients, the usual dose of DEPO-TESTOSTERONE is 200 to 400 mg injected
at intervals of three to four weeks. It is usually preferable to begin
treatment with full therapeutic doses, which are later adjusted to individual
requirements.
Priapism is a sign of excessive dosage and is an indication for temporary
withdrawal of androgen therapy.
Impotence due to Testicular Deficiency; Male Climacteric - DEPO-TESTOSTERONE
may be given every three to four weeks in doses ranging from 200 to
400 mg.
Oligospermia - To stimulate spermatogenesis when trial androgen therapy
is indicated in subfertile males with oligospermia, recommended dosage
of DEPO-TESTOSTERONE is: (1) 100 to 200 mg every three to six weeks
for development and maintenance of testicular function; (2) 200 mg each
week for six to ten weeks for suppression which may then be followed
by rebound spermatogenesis following discontinuance of the injection.
Anabolic Effect; Osteoporosis - The dosage of DEPO-TESTOSTERONE for
anabolic effect should be adjusted according to age, sex, and the condition
of the individual patient. In the majority of cases, the dose will range
from 200 to 400 mg injected every three to four weeks. In addition,
an adequate diet should be provided and prolonged immobilization avoided
whenever possible.
SIDE EFFECTS AND SPECIAL PRECAUTIONS
Hypercalcaemia may occur in immobilized patients, and in patients with
breast cancer. In patients with cancer this may indicate progression
of bony metastasis. If this occurs the drug should be discontinued.
Testosterone propionate must not be used interchangeably with testosterone
cypionate, enanthate or phenylacetate due to the difference in duration
of action.
Do not give intravenously.
Watch female patients closely for signs of virilization. Some effects
such as voice changes may not be reversible when the drug is stopped.
Due to the prolonged action of this drug, it should be administered
with caution to patients with organic heart disease of debilitation.
Patients with cardiac, renal or hepatic derangement may retain sodium
and water thus forming oedema.
Priapism or excessive sexual stimulation may develop. Oligospermia
and reduced ejaculatory volume may occur after prolonged administration
or excessive dosage. Hypersensitivity and gynecomastia may occur. When
any of these effects appear the androgen should be stopped and if restarted,
a lower dosage should be utilized.
The PBI may increase during androgen therapy without clinical significance.
* Acne Priapism
* Decreased ejaculatory volume
* Hypercalcaemia (especially in immobile patients Gynecomastia and those
with metastatic breast carcinoma)
* Oedema
* Local irritation
* Hypersensitivity, including skin manifestations and anaphylactiod
reactions
* Virilization in females
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT
Treatment should be symptomatic and supportive.
IDENTIFICATION
A pale yellow oily solution.
PRESENTATION
TESTOSTERONE 100 mg or 200mg is available in 10 mL vials.
STORAGE INSTRUCTIONS
Store at room temperature (15?C - 30?C) Keep out of reach of children
Low Testosterone Could Kill You
Low Levels of Male Hormone May be More Dangerous Than Previously Thought
By SUPINDA BUNYAVANICH, M.D.
ABC News Medical Unit
June 6, 2007
Low testosterone may lead to a greater risk of death,
according to a study presented Tuesday at the annual meeting of the
Endocrine Society in Toronto.
New research suggests that men with low testosterone levels may be
at increased risk of early death.
Men with low testosterone had a 33 percent greater death
risk over their next 18 years of life compared with men who had higher
testosterone, according to the study conducted by Dr. Elizabeth Barrett-Connor
and colleagues at the University of California at San Diego.
"It's very exciting and potentially a groundbreaking
study," said Barrett-Connor. "But it needs to be confirmed."
The study tracked nearly 800 men, 50 to 91 years old,
living in California. Their testosterone level was measured at the
beginning of the study, and their health was then tracked over the
next 20 years.
How Low Is Low?
Testosterone normally declines as men get older. However,
a clear definition of "low" testosterone does not yet exist.
"No one knows what low really is," said Dr.
Joel Finkelstein, endocrinologist and associate professor at Harvard
Medical School. "The study authors defined it at 250 [nanograms
per deciliter], which is a definition, but no one has figured out
what low is."
Barrett-Connor and her colleagues found that nearly
30 percent of the men they studied met their criterion score of 250
or lower for low testosterone.
They noted that many men with this definition of low
testosterone were "healthy men in the community who would not
know that they had low testosterone."
Men With Hot Flashes
Symptoms of low testosterone depend on how low the level
is. At the lowest levels, men will have hot flashes, much like those
experienced by women during menopause.
"At levels not quite that low, men have decreases
in their libido, erectile dysfunction, fatigue and physiological changes
many will not immediately recognize," Finkelstein said, adding
that these could include loss of strength, decrease in bone density
and decreased muscle mass.
However, absent symptoms, there is no reason to get
testosterone treatment.
Souce: www.abcnews.go.com

Testosterone Depo
Tetosterone Depo is the most popular and most used testosterone. Cypionate,
like Enanthate (another form of testosterone), is an oil-dissolved injectable
form of testosterone with strong androgenic and anabolic effects. It
aromatizes quite easily which means that the conversion rate to estrogen,
similar to Enanthate's, is relatively high. Several individuals are
of the opinion that Cypionate stores more water in the body than enanthate
does. The muscle buildup during the application along with the inevitable
loss of strength and muscle mass after discontinuing use of one product,
are the same with the other. Testosterone Cypionate can be combined
with many steroids and thus making it an excellent mass steroid.
This oil based injectable form of testosterone can cause a marked
disturbance in the body's endogenous production of testosterone if not
carefully monitored and cycled. There are many claims that this drug
produces dramatic size and strength increases, yet some studies disprove
any strength gain. It can be combined with a number of different steroids
to yield greater results. Cypionate is produced domestically under the
brand name Depo-Testosterone and other manufacturers produce it under
generic names.
Testosterone Enanthate
DELATESTRYL (Testosterone Enanthate Injection) provides testosterone
enanthate, a derivative of the primary endogenous androgen testosterone,
for intramuscular administration. In their active form, androgens have
a 17-beta-hydroxy group. Esterification of the 17-beta-hydroxy group
increases the duration of action of testosterone; hydrolysis to free
testosterone occurs. Each mL of sterile, colorless to pale yellow solution
provides 200 mg testosterone enanthate in sesame oil with 5 mg chlorobutanol
(chloral derivative) as a preservative.
Testosterone Propionate
Testosterone Propionate is a common oil-based injectable Testosterone.
The added Propionate extends the activity of the Testosterone but it
is still comparatively much faster acting than other Testosterone esters
such as Cypionate and Enanthate. While Cypionate and Enanthate are injected
weekly, Propionate is most commonly injected at least every third day
to keep blood levels steady. For strength and muscle mass gains, this
drug is quite effective. With Propionate, androgenic side effects seem
somewhat less pronounced than with the other Testosterones, probably
due to the fact that blood levels do not build up as high. Users often
report less gyno trouble, lower water retention and commonly claim to
be harder on Propionate than with the others. This however is still
a Testosterone and, as with all Testosterone products, androgenic side
effects are unavoidable. It should also be noted that Propionate is
often a very painful injection. Users very regularly report swelling
and noticeable pain for days after a shot.
Nandrolone Decanoate
Known commonly as "Deca", this androgenic/anabolic steroid
(AAS) is easy on the liver and promotes good size and strength gains
while reducing body fat. This drug is unique in that 5a -reductase,
the enzyme which converts testosterone to the more-potent DHT, actually
converts Nandrolone to a less-potent compound. Therefore, this is somewhat
deactivated in the skin, scalp, and prostate, and these tissues experience
an effectively-lower androgen level than the rest of the body.
For those particularly concerned with less activity in the scalp,
skin, and prostate Deca is a good alternative in androgen therapy. Its
effectiveness at the androgen receptor of muscle tissue is better and
binds better than testosterone. Yet, it gives only about half the muscle-building
results per milligram. This is a due to it being less effective or entirely
ineffective in non-AR-mediated mechanisms for muscle growth. It also
appears less effective in activity on nerve cells, specifically on the
nerve cells responsible for erectile function. Use of Deca as the sole
AAS often results in complete inability to perform sexually. These problems
can be solved by combining it with a drug that supplies the missing
activity: e.g. testosterone.
Nandrolone is proven to be a progestin. This is important in bodybuilding,
because moderate Deca-only use actually lowers estrogen levels as a
consequence of reducing natural testosterone levels; thus allowing the
aromatase enzyme less substrate to work with, Deca nonetheless can cause
gynecomastia in some individuals.
To some extent, Nandrolone aromatizes to estrogen, and it does not
appear that this can be entirely blocked by use of aromatase inhibitors
- indeed, aromatase may not be involved at all in this process (there
is no evidence in humans that such occurs) with the enzyme CYP 2C11
being the more likely candidate for this activity. Cytadren, an aromatase
inhibitor, has not been found effective in avoiding aromatization of
Nandrolone.
The long half-life of Deca-Durabolin makes it unsuited for short alternating
cycles, but suitable for more traditional cycles, with a built-in self-tapering
effect in the weeks following the last injection.
Theraputic action: Testosterone analogue; promotes body tissue–building
processes and reverses catabolic or tissue-depleting processes; increases
Hgb and red cell mass.
How Taken - Administration by deep intermuscular Injection
Possible Side Effects - Water retention (edema), Gynecomastia, Numbness,
Inhibited natural testosterone production, Elevated blood pressure ,
Elevated blood lipid profiles, Accelerated hair loss , Aggression, moodiness
, Acne.
Contraindications/cautions
Known sensitivity to nandrolone or anabolic steroids; prostate or breast
cancer in males; benign prostatic hypertrophy; breast cancer (females);
pituitary insufficiency; MI (contraindicated because of effects on cholesterol);
nephrosis; liver disease; hypercalcemia; pregnancy; lactation.
Warnings/Precautions - Your doctor should check your progress at regular
visits and should check liver profiles at least twice a year.
Instructions to follow for your safety:
This drug can only be given IM; mark calendar indicating days to return
for injection.
• The following side effects may occur: nausea, vomiting, diarrhea,
burning of the tongue (small, frequent meals); body hair growth, baldness,
deepening of the voice, loss of libido, impotence; (most effects are
reversible); excitation, confusion, insomnia (avoid driving, performing
tasks that require alertness); swelling of the ankles, fingers (request
medication).
• This drug is associated with severe fetal effects; do not use
drug during pregnancy; use of barrier contraceptives is advised.
• Report ankle swelling, skin color changes, severe nausea, vomiting,
hoarseness, body hair growth, deepening of the voice, acne, menstrual
irregularities (women).
• Tell any healthcare provider who is taking care of you that
you are on this drug.
For diabetic patients:
This medicine may affect blood sugar levels. If you notice a change
in the results of your blood or urine sugar tests you should check with
your doctor for further analysis.
Missed Dose - Do not double up on medication. Missed doses should
be added to the end of cycle.
Pregnancy - Anabolic steroids are not recommended during pregnancy.
They may cause the development of male features in the female fetus
and premature growth and development of male features in the male fetus.
Be sure you have discussed this with your doctor.
Storage - Store in a cool, dry place. Keep the liquid form of this
medicine from freezing.
Clinically important interactions
Drug-drug:
• Potentiation of oral anticoagulants with anabolic steroids
• Decreased need for insulin, oral hypoglycemia agents with anabolic
steroids
Drug-lab test
• Altered glucose tolerance tests
• Decrease in thyroid function tests, which may persist for 2–3
wk after stopping therapy
• Increased creatinine, creatinine clearance, which may last for
2 wk after therapy
Nursing considerations - Assessment
History: Sensitivity to nandrolone or anabolic steroids; prostate
or breast cancer in males; benign prostatic hypertrophy; breast cancer
in females; pituitary insufficiency; MI; nephrosis; liver disease; hypercalcemia;
pregnancy; lactation
Physical: Skin color, texture; hair distribution pattern; affect,
orientation; abdominal exam, liver evaluation; serum electrolytes, serum
cholesterol levels, glucose tolerance tests, thyroid function tests,
long-bone x-ray (in children)
Interventions
• Ensure that patient is not pregnant before administering; advise
the use of barrier contraceptives during therapy.
• Inject nandrolone deeply into gluteal muscle.
• Intermittent administration decreases adverse effects.
• Monitor effect on children with long-bone x-rays every 3–6
mo; discontinue drug well before the bone age reaches the norm for the
patient's chronologic age.
• Monitor patient for edema; arrange for diuretic therapy.
• Monitor liver function, serum electrolytes, and consult with
physician for appropriate corrective measures.
• Measure cholesterol levels periodically in patients with high
risk for CAD.
• Monitor diabetic patients closely because glucose tolerance
may change; adjustments may be needed in insulin, oral hypoglycemic
dosage, and diet.
Drug-specific teaching points
• This drug can only be given IM; mark calendar indicating days
to return for injection.
The following side effects may occur:
nausea, vomiting, diarrhea, burning of the tongue (small, frequent meals);
body hair growth, baldness, deepening of the voice, loss of libido,
impotence; (most effects are reversible); excitation, confusion, insomnia
(avoid driving, performing tasks that require alertness); swelling of
the ankles, fingers (request medication).
• This drug is associated with severe fetal effects; do not
use drug during pregnancy; use of barrier contraceptives is advised.
• Diabetic patients—monitor urine sugar closely because
glucose tolerance may change. Report any abnormalities to physician,
so corrective action can be taken.
• Report ankle swelling, skin color changes, severe nausea,
vomiting, hoarseness, body hair growth, deepening of the voice, acne,
menstrual irregularities (women).
|